We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

No Cancer Risk for Telomerase Gene Therapy

News   Aug 21, 2018 | Original Press Release from the CNIO

 
No Cancer Risk for Telomerase Gene Therapy

Representative images of lungs treated with gene therapy vectors. The nuclei are in blue, alveolar type II cells in green and telomeres in red. Notice that lung cells treated with active telomerase present more intense telomeres indicating that they are longer as compared to lung cells treated with the null vectors or with an inactive telomerase. Credit: CNIO

 
 
 

RELATED ARTICLES

No Nose? No Problem! Scientists Discover That Plants Can Smell

News

Researchers have discovered the first steps of how information from odor molecules changes gene expression in plants. Manipulating plants' odor detection systems may lead to new ways of influencing plant behavior.

READ MORE

Genome Overlap in Human Mental Disorders and Canine Behavior

News

Researchers have identified two novel anxiety related genomic regions in German Shepherd dogs.

READ MORE

Oligodendrocytes are Different in the Brains of MS Patients

News

Fresh insights into the types of cells found in the brains of people with multiple sclerosis could help develop improved therapies, research has found.




READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE